Literature DB >> 11849452

Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.

David A Bushinsky1, John R Asplin, Marc D Grynpas, Andrew P Evan, Walter R Parker, Kristen M Alexander, Fredric L Coe.   

Abstract

BACKGROUND: Over 54 generations, we have successfully bred a strain of rats that maximizes urinary calcium excretion. The rats now consistently excrete 8 to 10 times as much calcium as controls, uniformly form poorly crystalline calcium phosphate kidney stones, and are termed genetic hypercalciuric stone-forming (GHS) rats. These rats were used to test the hypothesis that increasing urinary oxalate excretion would not only increase the supersaturation with respect to the calcium oxalate solid phase, but also would increase the ratio of calcium oxalate-to-calcium phosphate supersaturation and result in calcium oxalate stone formation.
METHODS: To increase urine oxalate excretion an oxalate precursor, hydroxyproline, was added to the diet of male GHS rats. The GHS rats were fed a standard 1.2% calcium diet alone or with 1%, 3% or 5% trans-4-hydroxy-l-proline (hydroxyproline).
RESULTS: The addition of 1% hydroxyproline to the diet of GHS rats led to an increase in urinary oxalate excretion, which did not increase further with the provision of additional hydroxyproline. The addition of 1% and 3% hydroxyproline did not alter calcium excretion while the provision of 5% hydroxyproline led to a decrease in urine calcium excretion. The addition of 1% hydroxyproline led to an increase in urinary calcium oxalate supersaturation, which did not further increase with additional hydroxyproline. The addition of 1% and 3% hydroxyproline did not alter urinary supersaturation with respect to calcium hydrogen phosphate while the addition of 5% hydroxyproline tended to lower this supersaturation. Compared to rats fed the control and the 3% hydroxyproline diet the addition of 5% hydroxyproline increased the ratio of calcium oxalate supersaturation to calcium phosphate supersaturation. Virtually all rats formed stones. In the control and 1% hydroxyproline group, all of the stones were composed of calcium and phosphate (apatite), in the 3% hydroxyproline group the stones were a mixture of apatite and calcium oxalate, while in the 5% hydroxyproline group all of the stones were calcium oxalate.
CONCLUSIONS: The provision of additional dietary hydroxyproline to GHS rats increases urinary oxalate excretion, calcium oxalate supersaturation and the ratio of calcium oxalate-to-calcium phosphate supersaturation, resulting in the formation of calcium oxalate kidney stones. Thus, with the addition of a common amino acid, the GHS rats now not only model the most common metabolic abnormality found in patients with nephrolithiasis, hypercalciuria, but form the most common type of kidney stone, calcium oxalate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849452     DOI: 10.1046/j.1523-1755.2002.00190.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  35 in total

1.  Nephrolithiasis: site of the initial solid phase.

Authors:  David A Bushinsky
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

2.  Nephrolithiasis and nephrocalcinosis in rats with small bowel resection.

Authors:  R Corey O'Connor; Elaine M Worcester; Andrew P Evan; Shane Meehan; Dimitri Kuznetsov; Brett Laven; Andre' J Sommer; Sharon B Bledsoe; Joan H Parks; Fredric L Coe; Marc Grynpas; Glenn S Gerber
Journal:  Urol Res       Date:  2005-05

3.  Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.

Authors:  Nancy S Krieger; John R Asplin; Ignacio Granja; Felix M Ramos; Courtney Flotteron; Luojing Chen; Tong Tong Wu; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2019-05-17       Impact factor: 10.121

Review 4.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

5.  Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease.

Authors:  Renato Ribeiro Nogueira Ferraz; Jonathan Mackowiak Fonseca; Gregory George Germino; Luiz Fernando Onuchic; Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2014-05-10       Impact factor: 3.436

Review 6.  Genetic basis of renal cellular dysfunction and the formation of kidney stones.

Authors:  Saeed R Khan; Benjamin K Canales
Journal:  Urol Res       Date:  2009-06-11

7.  The relation between bone and stone formation.

Authors:  Nancy S Krieger; David A Bushinsky
Journal:  Calcif Tissue Int       Date:  2012-12-18       Impact factor: 4.333

8.  Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Authors:  Kevin K Frick; John R Asplin; Christopher D Culbertson; Ignacio Granja; Nancy S Krieger; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-26

Review 9.  New insights into the pathogenesis of idiopathic hypercalciuria.

Authors:  Elaine M Worcester; Fredric L Coe
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

10.  Dissecting the genetic basis of kidney tubule response to hyperoxaluria using chromosome substitution strains.

Authors:  John H Wiessner; Michael R Garrett; Richard J Roman; Neil S Mandel
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.